Source: Medicines Authority (MT) Revision Year: 2023 Publisher: Laboratoires Bailleul S.A., 10-12 Avenue Pasteur, L-2310 Luxembourg – Luxembourg
Minorga 2%, cutaneous solution.
Pharmaceutical Form |
---|
Cutaneous solution. Clear and colorless or slightly yellow solution with an alcohol odor. |
Minoxidil 20 mg/ml (2% w/v).
One spray of Minorga 2% cutaneous solution contains 2.8 mg of minoxidil. Seven sprays are required to apply approximately 1 ml of solution containing 20 mg of minoxidil.
Excipient with known effect: propylene glycol.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Minoxidil |
Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative). |
List of Excipients |
---|
Propylene glycol |
HDPE Bottle with spray pump/applicators containing 60 ml of solution.
Pack sizes:
1 × 60 ml with 1 removable actuator with nozzle and 1 removable actuator with rod.
3 × 60 ml with 3 removable actuators with nozzle and 2 removable actuators with rod.
Not all pack sizes may be marketed.
Laboratoires Bailleul S.A., 10-12 Avenue Pasteur, L-2310 Luxembourg – Luxembourg
MA1106/00201
Date of first authorisation: 30th September, 2014
Date of latest renewal: 20th August, 2019
Drug | Countries | |
---|---|---|
MINORGA | Malta, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.